Tag: Cardiology
-
Sex May Influence Effectiveness of Common Heart Failure Drug
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
-
Investigating Risk of Heart Failure Through Adulthood
High levels of albumin — the most abundant protein in the bloodstream — present in one’s urine may indicate a higher risk of heart failure later in life, according to a study published in JAMA Cardiology.
-
New Insights in Cardiac Development
A new study published previously unknown details about the lineage of lymphatic endothelial cells associated with the heart.
-
Top 5 Breakthroughs Podcasts of 2019
Listen to a selection of the most popular episodes of the Breakthroughs podcast series produced in 2019, including a possible Amish fountain of youth, artificial intelligence, the rise of food allergies and more.
-
Pacemakers Could Help Avoid Future Strokes
Measuring atrial fibrillation through implanted devices like pacemakers can identify patients at risk for stroke, according to a recent study.
-
Medical Student Honored for Efforts to Combat Health Disparities
Ramael Ohiomoba, a second-year student, was one of two medical students in the country to be awarded the Dr. Richard Allen Williams Scholarship through the Association of Black Cardiologists.
-
Diabetes Drug May Help Treat Heart Failure Too
A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
-
New Heart Failure Drug Fails to Reduce Hospitalizations
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.
-
Total Heart Disease Deaths on The Rise
Total deaths from heart disease, stroke, diabetes and hypertension have been increasing since 2011, according to a new Northwestern Medicine study.
-
New Heart Failure Drug Shows Little Benefit
A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
